Inhibrx Biosciences News

4: Statement of changes in beneficial ownership of securities-Director Kayyem Jon Faiz

Jun 24 17:31 ET

EFFECT: Others

Jun 20 06:03 ET

424B3: Prospectus

Jun 18 17:33 ET

8-K: Current report

Jun 17 16:06 ET

Inhibrx Biosciences | CORRESP: CORRESP

Jun 14 15:34 ET

Inhibrx Biosciences | UPLOAD: Others

Jun 14 15:34 ET

S-1: General form for registration of securities under the Securities Act of 1933

Jun 11 17:14 ET

4: Statement of changes in beneficial ownership of securities-Director Kayyem Jon Faiz

Jun 7 18:07 ET

3: Initial statement of beneficial ownership of securities-10% Owner VIKING GLOBAL INVESTORS LP

Jun 7 16:28 ET

SC 13G: Statement of acquisition of beneficial ownership by individuals-Viking Global Investors LP(12.3%),Viking Global Opportunities Parent GP LLC(12.3%), etc.

Jun 7 16:28 ET

Inhibrx Biosciences | 4: Statement of changes in beneficial ownership of securities

Jun 4 17:33 ET

Inhibrx Biosciences | SC 13D: Statement of acquisition of beneficial ownership by individuals

Jun 3 20:46 ET

Inhibrx Biosciences | SC 13D: Statement of acquisition of beneficial ownership by individuals

Jun 3 20:46 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viking Global Investors LP(0.0%),Viking Global Opportunities Parent GP LLC(0.0%), etc.

Jun 3 18:01 ET

4: Statement of changes in beneficial ownership of securities-10% Owner VIKING GLOBAL INVESTORS LP

Jun 3 17:56 ET

Inhibrx Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals

May 31 16:39 ET

4: Statement of changes in beneficial ownership of securities-10% Owner Inhibrx, Inc.

May 31 16:36 ET

Inhibrx Biosciences | 4: Statement of changes in beneficial ownership of securities

May 31 16:35 ET

Inhibrx Biosciences | 8-K: Current report

May 30 09:07 ET

Inhibrx Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 30 09:07 ET